Results 111 to 120 of about 95,094 (198)

Scientists’ perception of ethical issues in nanomedicine: a case study [PDF]

, 2011
Helena Silva Costa, Sebastian Sethe, Ana Paula Pêgo, I. Anna S. Olsson   +3 more
openalex   +1 more source

Recent development of nanomedicine for the treatment of inflammatory diseases

, 2009
Megumu Higaki
openalex   +2 more sources

Is nanomedicine still promising? [PDF]

, 2011
Pubudu M. Peiris, Efstathios Karathanasis   +1 more
openalex   +1 more source

Nanomedicine and Optic Nerve Regeneration—Implications for Ophthalmology [PDF]

, 2011
Rajesh C. Rao, Dong Feng Chen
openalex   +1 more source

Delivering nanomedicine to solid tumors

Nature Reviews Clinical Oncology, 2010
R. Jain, T. Stylianopoulos
semanticscholar   +1 more source

Response to Article "Regenerative Potential Nanomedicine of Adipocyte Stem Cell-Derived Exosomes in Senescent Skin Tissue" [Letter]. [PDF]

Int J Nanomedicine
Tan Y, Zeng Y, Li R.
europepmc   +1 more source

Knowledge structure and dynamic evolution of nanomedicine in liver cancer research: a scientometric analysis and visualization. [PDF]

Front Pharmacol
Li S, Cui D, Shao B, Kang Z, Yan G.
europepmc   +1 more source

Label-Free Isothermal Amplification Assay for Specific and Highly Sensitive Colorimetric miRNA Detection

ACS Omega, 2016
Stefano Persano, Maria L. Guevara, Joy Wolfram, Elvin Blanco, Haifa Shen, Mauro Ferrari, Pier Paolo Pompa   +6 more
doaj   +1 more source

Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective

EBioMedicine
Summary: Increasing evidence indicates that immunotherapy is hindered by a hostile tumor microenvironment (TME) featured with deprivation of critical nutrients and pooling of immunosuppressive metabolites.
Jieyu Liu, Yinan Bai, Yinggang Li, Xiaoling Li, Kui Luo   +4 more
doaj  

Mesoporous Silica Nanoparticles: Their Projection in Nanomedicine [PDF]

, 2012
Maria Vallet‐Regí
openalex   +1 more source